These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38290972)

  • 41. CCAAT enhancer binding protein delta activates vesicle associated membrane protein 3 transcription to enhance chemoresistance and extracellular PD-L1 expression in triple-negative breast cancer.
    Zhao Y; Yu Y; Li X; Guo A
    J Exp Clin Cancer Res; 2024 Apr; 43(1):115. PubMed ID: 38627816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer.
    Desai PP; Narra K; James JD; Jones HP; Tripathi AK; Vishwanatha JK
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
    Holmes B; Benavides-Serrato A; Freeman RS; Landon KA; Bashir T; Nishimura RN; Gera J
    Oncogene; 2018 Feb; 37(6):732-743. PubMed ID: 29059166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The FACT complex facilitates expression of lysosomal and antioxidant genes through binding to TFEB and TFE3.
    Jeong E; Martina JA; Contreras PS; Lee J; Puertollano R
    Autophagy; 2022 Oct; 18(10):2333-2349. PubMed ID: 35230915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.
    Zhen Y; Zhao R; Wang M; Jiang X; Gao F; Fu L; Zhang L; Zhou XL
    Theranostics; 2020; 10(18):8080-8097. PubMed ID: 32724459
    [No Abstract]   [Full Text] [Related]  

  • 46. TNFSF13 upregulation confers chemotherapeutic resistance via triggering autophagy initiation in triple-negative breast cancer.
    Lin HY; Kuei CH; Lee HH; Lin CH; Chen YL; Chen CL; Lin YF
    J Mol Med (Berl); 2020 Sep; 98(9):1255-1267. PubMed ID: 32671412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in a mouse lung cancer stem cell model.
    Andey T; Marepally S; Patel A; Jackson T; Sarkar S; O'Connell M; Reddy RC; Chellappan S; Singh P; Singh M
    J Control Release; 2014 Jun; 184():67-78. PubMed ID: 24727000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. (R)-9bMS Inhibited the Protein Synthesis and Autophagy of Triple Negative Breast Cancer Cells
    Bai X; Han G; Li F; Li W; Bu P; Zhang H; Xie J
    Protein Pept Lett; 2023; 30(4):295-303. PubMed ID: 36861798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers.
    Lefort S; Joffre C; Kieffer Y; Givel AM; Bourachot B; Zago G; Bieche I; Dubois T; Meseure D; Vincent-Salomon A; Camonis J; Mechta-Grigoriou F
    Autophagy; 2014; 10(12):2122-42. PubMed ID: 25427136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells.
    Yang F; Wang F; Liu Y; Wang S; Li X; Huang Y; Xia Y; Cao C
    Life Sci; 2018 Nov; 213():149-157. PubMed ID: 30352240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PYCR3 modulates mtDNA copy number to drive proliferation and doxorubicin resistance in triple-negative breast cancer.
    Zhuang F; Huang S; Liu L
    Int J Biochem Cell Biol; 2024 Jun; 171():106581. PubMed ID: 38642827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.
    Gibbs LD; Vishwanatha JK
    Oncotarget; 2018 Jan; 9(2):2697-2704. PubMed ID: 29416802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
    Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
    Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Near-infrared photothermal therapy using EGFR-targeted gold nanoparticles increases autophagic cell death in breast cancer.
    Zhang M; Kim HS; Jin T; Moon WK
    J Photochem Photobiol B; 2017 May; 170():58-64. PubMed ID: 28390259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells.
    Das S; Shetty P; Valapala M; Dasgupta S; Gryczynski Z; Vishwanatha JK
    Biochemistry; 2010 Mar; 49(10):2216-26. PubMed ID: 20121258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
    Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R
    Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer.
    Shetty PK; Thamake SI; Biswas S; Johansson SL; Vishwanatha JK
    PLoS One; 2012; 7(9):e44299. PubMed ID: 22957061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.
    Zheng L; Foley K; Huang L; Leubner A; Mo G; Olino K; Edil BH; Mizuma M; Sharma R; Le DT; Anders RA; Illei PB; Van Eyk JE; Maitra A; Laheru D; Jaffee EM
    PLoS One; 2011 Apr; 6(4):e19390. PubMed ID: 21572519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autophagy drives fibroblast senescence through MTORC2 regulation.
    Bernard M; Yang B; Migneault F; Turgeon J; Dieudé M; Olivier MA; Cardin GB; El-Diwany M; Underwood K; Rodier F; Hébert MJ
    Autophagy; 2020 Nov; 16(11):2004-2016. PubMed ID: 31931659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.